Dexrazoxane HPLC Analysis Gradient Elution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current chromatography technologies are inadequate for effectively separating impurities from active pharmaceutical ingredients or preparations of dexrazoxane, with short retention times and limited detection of impurities, failing to meet the need for efficient and rapid analysis of dexrazoxane-related substances.
Innovation Solution
A high-performance liquid chromatography method employing a low-density bonding reversed-phase C18 chromatographic column with gradient elution using a buffer as mobile phase A and an organic solvent as mobile phase B, with specific conditions such as a volume percent content of mobile phase A not lower than 90% in the first stage of gradient elution, and a duration of 15-30 minutes, to achieve efficient separation of impurities and main peaks.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional chromatography technology is used, then the analysis method is simple, but the separation capability of impurities from active pharmaceutical ingredients is poor and retention times are too short
Solution Approach 1:
The patent applies parameter changes by transitioning from isocratic to gradient elution, adjusting the mobile phase composition dynamically during chromatography. The mobile phase B percentage increases from 5% to 40% over time, which optimizes the separation of different impurities with varying polarities and improves retention times while maintaining method simplicity
Solution Approach 2:
The patent implements dynamics by using gradient elution where the mobile phase composition changes continuously during the chromatographic run. This dynamic adjustment of solvent strength allows for better separation of impurities that have different affinities for the stationary phase, resolving the contradiction between separation capability and method complexity
2Quantity of substance
If conventional chromatography conditions are used, then the analysis is rapid, but the number of impurities detected is very few (only 3-4 impurities)
Solution Approach 1:
The gradient elution program is designed to increase mobile phase B from 5% to 40% over 20 minutes, with different stages optimized for detecting different impurities. This parameter change enables the detection of multiple impurities (more than 3-4) with varying polarities within a reasonable time frame, balancing quantity of detected impurities with analysis time
3Manufacturing precision
If isocratic elution is used, then the method is simple to operate, but the resolution between impurities and main peaks is not compliant
Solution Approach 1:
The patent uses gradient elution where the mobile phase composition dynamically changes during the run, starting with 95% mobile phase A and 5% mobile phase B, then increasing mobile phase B to 40% by minute 20. This dynamic approach improves resolution between impurities and main peaks compared to isocratic elution, while the gradient program remains automated and easy to operate
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for better retention and separation of main degradation impurities, increases the number of detected impurities, and improves repeatability, sensitivity, and accuracy, providing an effective detection method for controlling the quality of dexrazoxane and its preparations.
Implementation Method 1
a low-density bonding reversed-phase C18 chromatographic column resist to pure water is employed
Implementation Method 2
reversed-phase C18 chromatographic column
Implementation Method 3
a gradient elution is carried out with a mobile phase A and a mobile phase B as the eluents
Implementation Method 4
gradient elution with a mobile phase A and a mobile phase B
Data Source
AI summary
A high performance liquid chromatography method used for dexrazoxane-related substances is provided, and in the method, a low-density bonding reversed-phase C18 chromatographic column resistant to pure water is employed; a gradient elution is carried out with mobile phase A and mobile phase B as eluents, the mobile phase A being a buffer, and the mobile phase B being an organic solvent; the volume percent of mobile phase A in eluents in a first stage of the gradient elution is not lower than 90%, and the duration of the first stage of the gradient elution ranges from 15˜30 minutes. By means of the analytical method, dexrazoxane is effectively separated from main impurities, and the qualities of the active pharmaceutical ingredients of dexrazoxane and the preparations thereof could be better controlled.